Drug-induced morphea: report of a case induced by balicatib and review of the literature

Journal of the American Academy of Dermatology
Anna PeroniGiampiero Girolomoni

Abstract

Drug-induced scleroderma has been rarely reported, mostly with the features of diffuse scleroderma or acrosclerosis, and exceptionally with the characteristics of morphea. We report the case of an adult white woman, enrolled in a double-blind, placebo-controlled, multicentric trial evaluating the efficacy and safety of the cathepsin K inhibitor balicatib for osteoporosis. Typical morphea lesions developed on the patient's trunk 9 months after the beginning of therapy. Lesions completely resolved after drug withdrawal and a single brief course of systemic steroids. No recurrence occurred in a 2-year follow-up. Fifteen cases of drug-induced morphea could be retrieved from the literature. Drug withdrawal determined complete remission in only a few patients. Different drug classes have been implicated. Some of these, including balicatib, alter directly connective tissue metabolism.

References

Jan 1, 1991·Cell Biochemistry and Function·H A Khalfan
Apr 1, 1989·International Journal of Dermatology·B LeshinR M Caplan
Nov 1, 1989·Annals of the Rheumatic Diseases·B J Liddle
Feb 1, 1981·Annals of the Rheumatic Diseases·R M BernsteinB E Gostelow
Oct 1, 1996·Journal of Korean Medical Science·K H KimT H Kim
Mar 5, 1998·Journal of the American Academy of Dermatology·J Alonso-Llamazares, I Ahmed
Jun 27, 1998·Clinics in Dermatology·U F Haustein, B Haupt
May 27, 2004·The American Journal of Pathology·Frank BühlingTobias Welte
Jun 25, 2004·The British Journal of Dermatology·Y AsanoK Tamaki
Sep 10, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Julia HoRoberta Sengelmann
May 7, 2005·Advanced Drug Delivery Reviews·Yoshiyuki YasudaDieter Brömme
Dec 27, 2005·Current Topics in Medicinal Chemistry·David N Deaton, Francis X Tavares
Sep 2, 2006·The Journal of Investigative Dermatology·Thomas M RüngerJag Bhawan
Sep 20, 2006·Clinical Therapeutics·Trond KvernmoErich Burger
Dec 13, 2006·Lupus·S Vasoo
Aug 9, 2007·The Annals of Pharmacotherapy·Amy S Peak, Amy Sheller
Oct 18, 2007·Molecular Pharmacology·Sylvie DesmaraisM David Percival

❮ Previous
Next ❯

Citations

Jan 10, 2012·Current Osteoporosis Reports·Steven BoonenSocrates Papapoulos
Jan 29, 2013·Journal of Medicinal Chemistry·Jörg SchröderPaul M Selzer
Sep 3, 2010·Nature Reviews. Clinical Oncology·Tomifumi OnishiNaoto T Ueno
May 11, 2011·Nature Reviews. Clinical Oncology·Justin SturgeJonathan Waxman
Jun 15, 2011·Nature Reviews. Rheumatology·Aline G CostaJohn P Bilezikian
May 15, 2013·The American Journal of Dermatopathology·Cynthia M MagroGerard J Nuovo
Mar 23, 2010·American Journal of Therapeutics·Chandrasekar PalaniswamyUmesh Patel
Jun 2, 2011·Respiratory Research·Dongwei ZhangDieter Brömme
Aug 7, 2012·Clinical Interventions in Aging·Kong Wah Ng
Jan 19, 2013·Chinese Journal of Cancer·Kenneth C ValkenburgZhendong Zhong
Nov 9, 2010·Annual Review of Medicine·Barbara C Silva, John P Bilezikian
Sep 18, 2008·Archives of Dermatological Research·Camilla Dalle VedoveGiampiero Girolomoni
Feb 18, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R RizzoliD Gurner
Jan 1, 2013·Journal of Clinical Medicine·Wajeeha Razaq
Apr 25, 2009·Expert Opinion on Investigational Drugs·Dieter Brömme, Fabien Lecaille
Dec 3, 2008·Expert Opinion on Emerging Drugs·J C M ClarkPeter F M Choong
Mar 3, 2009·Expert Opinion on Emerging Drugs·E Michael Lewiecki
Feb 7, 2016·La Revue de médecine interne·S DeshayesL Geffray
Apr 20, 2013·Rheumatic Diseases Clinics of North America·Aaliya YaqubDavid F Fiorentino
May 17, 2011·Journal of the American Academy of Dermatology·Thomas M RüngerVanessa Smith
Apr 1, 2011·Lancet·Tilman D RachnerLorenz C Hofbauer
Jan 18, 2011·Journal of the American Academy of Dermatology·Nicole Fett, Victoria P Werth
Nov 26, 2010·Journal of the American Academy of Dermatology·Ana Maria CalistruFilomena Azevedo
Sep 2, 2008·Seminars in Cell & Developmental Biology·Ian R Reid
May 28, 2009·Experimental Dermatology·Maria J Quintanilla-DieckThomas M Rünger
Dec 17, 2008·Pharmacoepidemiology and Drug Safety
Jun 30, 2012·Dermatologic Therapy·Alexander Kreuter
Aug 27, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·John A EismanAntonio Lombardi
May 26, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Christopher J YatesPeter R Ebeling
Feb 12, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellSteve Deacon
Jul 11, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Bente LangdahlAlbert Leung
Jul 23, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellSteve Deacon
Mar 24, 2016·Expert Opinion on Drug Discovery·Dieter BrömmeSerap Turan
Sep 1, 2015·Clinics in Dermatology·Anna Gorkiewicz-Petkow, Agnieszka Kalinska-Bienias
Jul 8, 2015·Expert Opinion on Pharmacotherapy·Miranda K BoggildAngela M Cheung
Mar 10, 2012·Pharmacology & Therapeutics·Tilman D RachnerLorenz C Hofbauer
Jan 13, 2015·Wiener medizinische Wochenschrift·Marion Gamsjäger, Heinrich Resch
Sep 10, 2014·Journal of Endocrinological Investigation·S IshtiaqG Hampson
Apr 24, 2016·Biochemical Pharmacology·Kakoli Mukherjee, Naibedya Chattopadhyay
Aug 27, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Erica J CarboneKevin W-H Lo
Sep 25, 2016·Actas dermo-sifiliográficas·A Alegre-SánchezE de Las Heras-Alonso
Mar 18, 2017·American Journal of Clinical Dermatology·Jorre S MertensElke M G J de Jong
Aug 25, 2016·The British Journal of Dermatology·A M SaracinoC H Orteu
Apr 28, 2012·Dermatology : International Journal for Clinical and Investigative Dermatology·M M TangL Borradori
Jul 5, 2013·The American Journal of Dermatopathology·Tanya Angela Perez-ChuaJag Bhawan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Henry G BoneB Avery Ince
The New England Journal of Medicine
Julie Schwartzman, Yusuf Yazici
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Xiaodong LiChris Paszty
© 2022 Meta ULC. All rights reserved